Infections with human papillomaviruses (HPV) are a necessary, but not sufficient cause of cervical cancer. Cervical cancer develops over a long time through precursor lesions that can be detected by cytological screening. The majority of these lesions regress spontaneously without treatment. The challenge of cervical cancer screening is to detect the lesions that have a high risk of progression. Since the recently introduced vaccination against HPV cannot provide 100% protection, cervical cancer screening programs must continue. It is assumed that the reduction of precancers related to vaccination will have a negative impact on the efficiency of current screening programs. Therefore, participation rates need to be increased and current screening modalities should be improved. Several promising biomarkers have been described that might improve cervical cancer screening, but currently, high-quality studies on their efficiency are lacking.

Keywords:
Cervical cancer, Human papillomavirus, Cancer screening, Cytology, Biomarker, Human papillomavirus vaccination
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.